ACCESSION: MSBNK-SMB_Measured-HSA032P0370000
RECORD_TITLE: Characterized; N-palmitoyl leucine; LC-ESI-QTOF; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.25, Processed 2025.02.25, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 15.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 60
COMMENT: NUM_AVERAGED_SPEC 28
COMMENT: RAW_SPEC {'HC10-pos_6838': {'bp': 3327.0, 'sum': 7519.0}, 'HC20-pos_7128': {'bp': 3230.0, 'sum': 6215.0}, 'HC9-pos_6895': {'bp': 3092.0, 'sum': 6372.0}, 'RA6-pos_6765': {'bp': 3018.0, 'sum': 6731.0}, 'HC25-pos_6812': {'bp': 2999.0, 'sum': 5909.0}, 'HC9-pos_6909': {'bp': 2887.0, 'sum': 5645.0}, 'RA13-pos_6931': {'bp': 2789.0, 'sum': 6297.0}, 'HC22-pos_6908': {'bp': 2681.0, 'sum': 4345.0}, 'RA12-pos_7074': {'bp': 2378.0, 'sum': 5414.0}, 'HC2-pos_7111': {'bp': 2278.0, 'sum': 5610.0}, 'RA5-pos_7189': {'bp': 2168.0, 'sum': 4899.0}, 'HC4-pos_6887': {'bp': 2162.0, 'sum': 4856.0}, 'HC16-pos_7194': {'bp': 2159.0, 'sum': 5225.0}, 'HC15-pos_6890': {'bp': 1657.0, 'sum': 4067.0}, 'HC8-pos_6613': {'bp': 1612.0, 'sum': 4071.0}, 'RA10-pos_6996': {'bp': 1559.0, 'sum': 3401.0}, 'HC24-pos_6738': {'bp': 1498.0, 'sum': 2655.0}, 'RA19-pos_7007': {'bp': 1403.0, 'sum': 3388.0}, 'RA23-pos_6767': {'bp': 1384.0, 'sum': 2546.0}, 'RA2-pos_7087': {'bp': 1344.0, 'sum': 2445.0}, 'HC14-pos_6820': {'bp': 1191.0, 'sum': 2077.0}, 'RA17-pos_7091': {'bp': 1123.0, 'sum': 2782.0}, 'RA4-pos_6952': {'bp': 1051.0, 'sum': 2553.0}, 'RA8-pos_6336': {'bp': 820.0, 'sum': 2206.0}, 'RA18-pos_6835': {'bp': 779.0, 'sum': 1436.0}, 'HC7-pos_6935': {'bp': 752.0, 'sum': 2210.0}, 'RA25-pos_6964': {'bp': 571.0, 'sum': 1160.0}, 'RA24-pos_6548': {'bp': 467.0, 'sum': 1085.0}}
COMMENT: RETENTION_TIME_STDEV 0.007
COMMENT: PRECURSOR_M/Z_RAW 370.329729
COMMENT: PRECURSOR_M/Z_STDEV 0.000910
COMMENT: PRECURSOR_IN_MS1 mz 370.331895; int 126.767; delta(ppm) 11.182985
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+Na; mz 392.313486; int 28.214; cor 0.825
COMMENT: PROPOSED_ION_FORM M+Na; M+2Na-H; mz 392.313486; int 28.214; cor 0.825
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 7.034; C21H44N3P; [M+H]+; delta(ppm) -7.034461
COMMENT: PROPOSED_MF SevenGoldenRules 1.059; C22H43NO3; [M+H]+; delta(ppm) 1.058689
COMMENT: PROPOSED_MF SevenGoldenRules 3.856; C16H44N5O2P; [M+H]+; delta(ppm) 3.855686
COMMENT: PROPOSED_MF SevenGoldenRules 11.949; C17H43N3O5; [M+H]+; delta(ppm) 11.948836
COMMENT: PROPOSED_MF SevenGoldenRules 0.547; C19H46N3P; [M+Na]+; delta(ppm) -0.547010
COMMENT: PROPOSED_MF SevenGoldenRules 8.058; C20H45NO3; [M+Na]+; delta(ppm) 8.058323
COMMENT: PROPOSED_MF MS-FINDER 3.867; C22H43NO3; [M+H]+; delta(ppm) 1.053983
COMMENT: PROPOSED_MF MS-FINDER 2.928; C15H43N7OS; [M+H]+; delta(ppm) -0.797871
COMMENT: PROPOSED_MF MS-FINDER 2.772; C18H39N7O; [M+H]+; delta(ppm) 8.305186
COMMENT: PROPOSED_MF MS-FINDER 2.457; C18H47N3S2; [M+H]+; delta(ppm) 9.570010
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.490; C22H43NO3; [M+H]+; delta(ppm) 1.053983
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C22H43NO3; [M+H]+; delta(ppm) 1.053983
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.270; C22H43NO3; [M+H]+; delta(ppm) 1.053983
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.423; C23H43N2; [M+Na]+; delta(ppm) 24870.435403
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.515; C20H41N4O2; [M+H]+; delta(ppm) 4.679571
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.773; C18H39N7O; [M+H]+; delta(ppm) 8.305186
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.920; C8H35N17; [M+H]+; delta(ppm) -3.914511
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.753; C10H37N14O; [M+H]+; delta(ppm) -7.540037
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.057; C21H44N3P; [M+H]+; delta(ppm) -7.017594
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.290; C25H41N2; [M+H]+; delta(ppm) -6.182940
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C23H43N2; [M+Na]+; delta(ppm) 24870.435403
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C22H43NO3; [M+H]+; delta(ppm) 1.053983
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; UEWVQOCQZFYTBW-UHFFFAOYSA-N; C22H43NO3; Leu-C16:0
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; CCGXSETVBNBVKJ-UHFFFAOYSA-N; C22H43NO3; GABA-C18:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.025; UEWVQOCQZFYTBW-GNLPSFAGNA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(C)C)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.871; NGYZAEAXQQNUBZ-VCZXBEBONA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.510; WTOKUHHGBBPESF-ALDFUXCCNA-N; [M+H]+; CCCCCCCCCCCCCCC[C@H]1O[C@]1(C)C(=O)N[C@@H](C)CO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.433; RNRUHRONLFGPJY-UHFFFAOYSA-N; [M+H]+; O=C(OC1CCC(NC1C)CCCCCCCCCCCCC(O)C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.388; LPMBTLLQQJBUOO-MDZDMXLPSA-N; [M+H]+; CCCCCCCC\C=C\CCCCCCCC(=O)N(CCO)CCO
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.189; ASNURABVVXFZSH-CGWCWHFRSA-N; [M+H]+; aplidiasphingosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.597; RNRUHRONLFGPJY-UHFFFAOYSA-N; [M+H]+; (2R3R6S)-6-(13-Hydroxytetradecyl)-2-Methylpiperidin-3-Yl Acetate Hydrochloride
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.486; WTOKUHHGBBPESF-ALDFUXCCNA-N; [M+H]+; Semiplenamide F;(-)-Semiplenamide F;
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.476; NGYZAEAXQQNUBZ-VCZXBEBONA-N; [M+H]+; N-palmitoyl isoleucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.476; UEWVQOCQZFYTBW-GNLPSFAGNA-N; [M+H]+; N-palmitoyl leucine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.450; IAONXYMLFOCVGA-UFBKIKKCSA-N; [M+H]+; UNPD229559
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.447; LPMBTLLQQJBUOO-MDZDMXLPSA-N; [M+H]+; N,N-bis(2-hydroxyethyl)oleamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.404; GZYQCOWSXRFMPR-UNZNQWBTNA-N; [M+H]+; UNPD149192
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.305; CCGXSETVBNBVKJ-UHFFFAOYSA-N; [M+H]+; N-Stearoyl GABA
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ASNURABVVXFZSH-CGWCWHFRSA-N; [M+H]+; aplidiasphingosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; LPMBTLLQQJBUOO-MDZDMXLPSA-N; [M+H]+; N,N-bis(2-hydroxyethyl)oleamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.705; IAONXYMLFOCVGA-UFBKIKKCSA-N; [M+H]+; UNPD229559
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.628; GZYQCOWSXRFMPR-UNZNQWBTNA-N; [M+H]+; UNPD149192
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.468; RNRUHRONLFGPJY-UHFFFAOYSA-N; [M+H]+; (2R3R6S)-6-(13-Hydroxytetradecyl)-2-Methylpiperidin-3-Yl Acetate Hydrochloride
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; NGYZAEAXQQNUBZ-VCZXBEBONA-N; [M+H]+; N-palmitoyl isoleucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.431; UEWVQOCQZFYTBW-GNLPSFAGNA-N; [M+H]+; N-palmitoyl leucine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.178; WTOKUHHGBBPESF-ALDFUXCCNA-N; [M+H]+; Semiplenamide F;(-)-Semiplenamide F;
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.116; CCGXSETVBNBVKJ-UHFFFAOYSA-N; [M+H]+; N-Stearoyl GABA
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.129; LPMBTLLQQJBUOO-KTKRTIGZSA-N; [M+H]+; (Z)-N,N-bis(2-hydroxyethyl)octadec-9-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.466; CCGXSETVBNBVKJ-UHFFFAOYSA-N; [M+H]+; 4-(octadecanoylamino)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.463; UHEVUYWIUKQMTJ-KTKRTIGZSA-N; [M+H]+; 2-(2-hydroxyethylamino)ethyl (Z)-octadec-9-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.451; ULHGTPIJYDGNHZ-KTKRTIGZSA-N; [M+H]+; (Z)-N-[2-(2-hydroxyethoxy)ethyl]octadec-9-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.340; UCBLGIBMIAFISC-CQLAPORSSA-N; [M+H]+; N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.168; NGYZAEAXQQNUBZ-FPOVZHCZSA-N; [M+H]+; (2S,3S)-2-(hexadecanoylamino)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.465; GMHCJCQMNYOULB-UHFFFAOYSA-N; [M+H]+; 3-[methyl(octadecanoyl)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.464; MUNNIYAZGQGMQR-UHFFFAOYSA-N; [M+H]+; 2-(icosanoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -65.667; MUNNIYAZGQGMQR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.891; CCGXSETVBNBVKJ; [M+H]+; GABA-stearamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.823; LPMBTLLQQJBUOO; [M+H]+; Alrosol O
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -137.284; ULHGTPIJYDGNHZ; [M+H]+; Oleylamidoethylenoxyethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.066; GMHCJCQMNYOULB; [M+H]+; N-Methyl-N-(1-oxooctadecyl)-beta-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.292; SKYMEVDZQINENG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.397; RQFMXXMHBDZPOZ; [M+H]+; carboxymethyl-dimethyl-octadecanoylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.845; UHEVUYWIUKQMTJ; [M+H]+; Diethanolamine, oleate ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.653; IAONXYMLFOCVGA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -243.530; RNRUHRONLFGPJY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.362; WTOKUHHGBBPESF; [M+H]+; Semiplenamide F
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.839; ASNURABVVXFZSH; [M+H]+; Aplidiasphingosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.254; INEYIRFSQAWYPP; [M+H]+; Oxiranylmethyl octadecylcarbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -294.579; GZYQCOWSXRFMPR; [M+H]+; 3-[(3aS,6S,6aS)-6-tetradecyl-2,3,3a,4,6,6a-hexahydrofuro[3,4-d][1,3]oxazol-2-yl]propan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.624; LLLDDDDBYVCSGR; [M+H]+; 4,4(5H)-Oxazoledimethanol, 2-isoheptadecyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.649; FFJWPXULECNYBC; [M+H]+; 2-Heptadecyl-2-oxazoline-4,4-dimethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.580; MUNNIYAZGQGMQR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -129.488; UEWVQOCQZFYTBW; [M+H]+; N-palmitoyl leucine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -178.401; NGYZAEAXQQNUBZ; [M+H]+; (2S)-2-(hexadecanoylamino)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.053; MUNNIYAZGQGMQR; [M+H]+; Arachidoyl glycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -243.849; CCGXSETVBNBVKJ; [M+H]+; N-Stearoyl GABA
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -273.007; GMHCJCQMNYOULB; [M+H]+; Stearoyl methyl beta-alanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -277.905; SKYMEVDZQINENG; [M+H]+; N-[(E)-1,3-dihydroxyundec-4-en-2-yl]undecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -291.549; BKPCSYKXYHOPNR; [M+H]+; 4-(Octadecylamino)-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -324.938; FFJWPXULECNYBC; [M+H]+; 2-Heptadecyl-2-oxazoline-4,4-dimethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -328.167; RQFMXXMHBDZPOZ; [M+H]+; 2-[Dimethyl(octadecanoyl)azaniumyl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -340.751; IAONXYMLFOCVGA; [M+H]+; N-(1-hydroxy-3-methoxypropan-2-yl)octadec-4-enamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.899; UEWVQOCQZFYTBW; [M+H]+; N-palmitoyl leucine
COMMENT: CONFIDENCE Level 3: Tentative candidate, N-palmitoyl leucine, UEWVQOCQZFYTBW-GNLPSFAGNA-N; Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (4), MetFrag:MsfinderDB (6);
CH$NAME: N-palmitoyl leucine
CH$NAME: (2R)-2-(hexadecanoylamino)-4-methylpentanoic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C22H43NO3
CH$EXACT_MASS: 369.324294
CH$SMILES: CCCCCCCCCCCCCCCC(=O)N[C@H](CC(C)C)C(=O)O
CH$IUPAC: InChI=1S/C22H43NO3/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)23-20(22(25)26)18-19(2)3/h19-20H,4-18H2,1-3H3,(H,23,24)(H,25,26)/t20-/m1/s1
CH$LINK: INCHIKEY UEWVQOCQZFYTBW-HXUWFJFHSA-N
CH$LINK: LIPIDMAPS LMFA08020115
CH$LINK: PUBCHEM CID:10067704
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 5.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 15.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min,` 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.249
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 370.331961
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0019-9300000000-2a3cc0bd7886caa8b46c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  57.0695362 67.1969 57.069780 22.2536 38.61 0.4582 23 f{C4H9}/-5.97ppm,p-C18H35N1O3
  69.0695142 57.1929 69.069660 12.0024 25.48 0.5482 20 f{C5H9}/-5.25ppm,p-C17H35N1O3
  71.0857557 61.5200 71.085910 15.3195 24.72 0.7548 25 f{C5H11}/3.22ppm,p-C17H33N1O3
  85.1007959 53.9029 85.101007 19.8588 37.03 0.4859 21 f{C6H13}/-4.48ppm,p-C16H31N1O3
  86.0959376 999.0000 86.096153 6.7134 0.00 1.0000 28 f{C5H12N1}/-5.67ppm,p-C17H32O3
  95.0855671 54.2902 95.085825 14.1662 27.07 0.4821 24 f{C7H11}/0.42ppm,p-C15H33N1O3
  132.1016706 522.6626 132.102139 5.3746 145.34 0.9049 28 f{C6H14N1O2}/-1.78ppm,p-C16H30O1
PK$NUM_PEAK: 7
PK$PEAK: m/z int. rel.int.
  57.069536 67.20 67
  69.069514 57.19 57
  71.085756 61.52 61
  85.100796 53.90 53
  86.095938 999.00 999
  95.085567 54.29 54
  132.101671 522.66 522
//
